{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:21:46Z","timestamp":1794360106766,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"AFRA","award":["RAF6040"],"award-info":[{"award-number":["RAF6040"]}]},{"name":"Regional Office for the Eastern Mediterranean\/World Health organization","award":["RPC\/RAB&GH 10\/11-03"],"award-info":[{"award-number":["RPC\/RAB&GH 10\/11-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3009-9","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T12:14:25Z","timestamp":1519733665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco"],"prefix":"10.1186","volume":"18","author":[{"given":"Amal","family":"Oudghiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Chetioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathiah","family":"Zakham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal Eddine","family":"Bourkadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My Driss","family":"Elmessaoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Laglaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Chaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"El Mzibri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"3009_CR1","unstructured":"World Health Organization. World health statistics data. Geneva; 2009. http:\/\/www.who.int\/whosis\/whostat\/2009\/en\/ . Accessed 14th Apr 2017."},{"key":"3009_CR2","first-page":"10","volume":"107","author":"R Loddenkemper","year":"2010","unstructured":"Loddenkemper R, Hauer B. Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge. Dtsch Arztebl Int. 2010;107:10\u20139.","journal-title":"Dtsch Arztebl Int"},{"key":"3009_CR3","unstructured":"World Health Organization. Global Terculosis Report. Genova; 2016. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ . Accessed 14th Apr 2017."},{"key":"3009_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1086\/590009","volume":"47","author":"R Banerjee","year":"2008","unstructured":"Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, et al. Extensively drug resistant tuberculosis in California, 1993\u20132006. Clin Infect Dis. 2008;47:450\u20137.","journal-title":"Clin Infect Dis"},{"key":"3009_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","volume":"50","author":"A Aubry","year":"2006","unstructured":"Aubry A, Veziris N, Cambau E, Truffot-Pernot C, Jarlier V, Fisher LM. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob Agents Chemother. 2006;50:104\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","volume":"79","author":"S Ramaswamy","year":"1998","unstructured":"Ramaswamy S, Musser J. Molecular genetic basis of antimicrobial agent resistance in mycobacterium tuberculosis: 1998 update. Off J Int Union against Tuberc Lung Dis. 1998;79:3\u201329.","journal-title":"Off J Int Union against Tuberc Lung Dis"},{"key":"3009_CR7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","volume":"42","author":"GJ Alangaden","year":"1998","unstructured":"Alangaden GJ, Kreiswirth BN, Aouad A, Khetarpal M, Igno FR, Moghazeh SL, et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1998;42:1295\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.36.5.1220-1225.1998","volume":"36","author":"Y Suzuki","year":"1998","unstructured":"Suzuki Y, Katsukawa C, Tamaru AKI, Abe C, Makino M, Mizuguchi Y, et al. Detection of kanamycin-resistant mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. Clin Microbiol. 1998;36:1220\u20135.","journal-title":"Clin Microbiol"},{"key":"3009_CR9","doi-asserted-by":"publisher","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","volume":"7","author":"SB Georghiou","year":"2012","unstructured":"Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One. 2012;7:e33275.","journal-title":"PLoS One"},{"key":"3009_CR10","doi-asserted-by":"publisher","first-page":"e0117771","DOI":"10.1371\/journal.pone.0117771","volume":"10","author":"A Ali","year":"2015","unstructured":"Ali A, Hasan Z, McNerney R, Mallard K, Hill-Cawthorne G, Coll F, et al. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from pakistan. PLoS One. 2015;10:e0117771.","journal-title":"PLoS One"},{"key":"3009_CR11","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/JCM.01947-09","volume":"48","author":"F Brossier","year":"2010","unstructured":"Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2010;48:1683\u20139.","journal-title":"J Clin Microbiol"},{"key":"3009_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.molcel.2006.05.044","volume":"23","author":"SK Johansen","year":"2006","unstructured":"Johansen SK, Maus CE, Plikaytis BB, Douthwaite S. Capreomycin binds across the ribosomal subunit Interface using tlyA-encoded 2\u2032-O-methylations in 16S and 23S rRNAs. Mol Cell. 2006;23:173\u201382.","journal-title":"Mol Cell"},{"key":"3009_CR13","first-page":"20004","volume":"106","author":"MA Zaunbrecher","year":"2009","unstructured":"Zaunbrecher MA, Sikes RD, Metchock B, Shinnick TM, Posey JE. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Mol Cell. 2009;106:20004\u20139.","journal-title":"Mol Cell"},{"key":"3009_CR14","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T a peer-reviewed J Manag care. Hosp Formul Manag. 2015;40:277\u201383.","journal-title":"Hosp Formul Manag"},{"key":"3009_CR15","unstructured":"World Health Organization. Division of communicable diseases, surveillance. Anti-tuberculosis drug resistance in the world \/ the WHO\/IUATLD global project on anti-tuberculosis drug resistance surveillance. Report 2, prevalence and trends. Geneva; 2000. http:\/\/www.who.int\/iris\/handle\/10665\/66493.Accessed 14th Apr 2017."},{"key":"3009_CR16","first-page":"565","volume":"29","author":"G Canetti","year":"1963","unstructured":"Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull Wld Hlth Org. 1963;29:565\u201378.","journal-title":"Bull Wld Hlth Org"},{"key":"3009_CR17","unstructured":"David H, Frebault L, Thorel M. Methodes de Laboratoire pour Mycobact\u00e9riologie Clinique. Unit\u00e9 de tuberculose et des mycobacteries. Inst Pasteur Press. 1987:87."},{"key":"3009_CR18","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1128\/JCM.43.5.2471-2473.2005","volume":"43","author":"W Aldous","year":"2005","unstructured":"Aldous W, Pounder J, Cloud JL, Woods G. Comparison of six methods of extracting M. tuberculosis DNA from processed sputum for testing by quantitative real-time PCR. J Clin Microbiol. 2005;43:2471\u20133.","journal-title":"J Clin Microbiol"},{"key":"3009_CR19","first-page":"278","volume":"3","author":"I Chaoui","year":"2009","unstructured":"Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, et al. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries. 2009;3:278\u201384.","journal-title":"J Infect Dev Ctries"},{"key":"3009_CR20","unstructured":"World Health Organization. TB manual National Tuberculosis Programme Guideline. Warsaw; 2001. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0017\/123164\/E75464.pdf . Accessed 14th Apr 2017."},{"key":"3009_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/BF03175585","volume":"58","author":"R Sabouni","year":"2008","unstructured":"Sabouni R, Kourout M, Chaoui I, Jordaan A, Akrim M, Victor TC, et al. Molecular analysis of multidrug resistant Mycobacterium tuberculosis isolates from Morocco. Ann Microbiol. 2008;58:749\u201354.","journal-title":"Ann Microbiol"},{"key":"3009_CR22","first-page":"1440","volume":"13","author":"M Kourout","year":"2009","unstructured":"Kourout M, Chaoui I, Sabouni R, Lahlou O, El Mzibri M, Jordaan A, et al. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Morocco. Int J Tuberc Lung Dis. 2009;13:1440\u20132.","journal-title":"Int J Tuberc Lung Dis."},{"key":"3009_CR23","first-page":"207","volume":"6","author":"F Zakham","year":"2013","unstructured":"Zakham F, Chaoui I, Echchaoui AH, Chetioui F, Elmessaoudi MD, Ennaji MM, et al. Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco. Infect Drug Resist. 2013;6:207\u201313.","journal-title":"Infect Drug Resist"},{"key":"3009_CR24","first-page":"1095","volume":"28","author":"I Chaoui","year":"2014","unstructured":"Chaoui I, Atalhi N, Sabouni R, Akrim M, Abid M, Amzazi S, et al. Rifoligotyping assay: an alternative method for rapid detection of rifampicin resistance in Mycobacterium tuberculosis isolates from Morocco. Biotechnol Biotechnol. Equip. Taylor & Francis. 2014;28:1095\u2013102.","journal-title":"Taylor & Francis"},{"key":"3009_CR25","unstructured":"World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva; 2008. http:\/\/apps.who.int\/iris\/handle\/10665\/43831 . Accessed 14th Apr 2017."},{"key":"3009_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1164\/rccm.200308-1159OC","volume":"169","author":"ED Chan","year":"2004","unstructured":"Chan ED, Laurel V, Strand MJ, Chan JF, Huynh M-LN, Goble M, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004;169:1103\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"3009_CR27","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/AAC.00050-09","volume":"53","author":"S Feuerriegel","year":"2009","unstructured":"Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, R\u00fcsch-Gerdes S, et al. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother. 2009;53:3353\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/AAC.38.4.773","volume":"38","author":"HE Takiff","year":"1994","unstructured":"Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother. 1994;38:773\u201380.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR29","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1073\/pnas.94.18.9869","volume":"94","author":"S Sreevatsan","year":"1997","unstructured":"Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, et al. Restricted structural gene polymorphism in the mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A. 1997;94:9869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3009_CR30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1469-0691.2010.03087.x","volume":"16","author":"A Soudani","year":"2010","unstructured":"Soudani A, Hadjfredj S, Zribi M, Messaoud T, Masmoudi A, Majed B, et al. First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital. Clin Microbiol Infect. 2010;16:1454\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"3009_CR31","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1128\/AAC.48.8.3175-3178.2004","volume":"48","author":"MR Pasca","year":"2004","unstructured":"Pasca MR, Guglierame P, Arcesi F, Bellinzoni M, De Rossi E, Riccardi G. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2004;48:3175\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR32","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1128\/AAC.00036-08","volume":"52","author":"I Mokrousov","year":"2008","unstructured":"Mokrousov I, Otten T, Manicheva O, Potapova Y, Vishnevsky B, Narvskaya O, et al. Molecular characterization of ofloxacin-resistant mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother. 2008;52:2937\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR33","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1128\/AAC.00102-13","volume":"57","author":"Y Hu","year":"2013","unstructured":"Hu Y, Hoffner S, Wu L, Zhao Q, Jiang W, Xu B. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in rural china. Antimicrob Agents Chemother. 2013;57:3857\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR34","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1128\/JCM.00081-09","volume":"47","author":"D Hillemann","year":"2009","unstructured":"Hillemann D, R\u00fcsch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2009;47:1767\u201372.","journal-title":"J Clin Microbiol"},{"key":"3009_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1128\/JCM.00857-13","volume":"52","author":"M Hoshide","year":"2014","unstructured":"Hoshide M, Qian L, Rodrigues C, Warren R, Victor TC, Evasco HB, et al. Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol. 2014;52:1322\u20139.","journal-title":"J Clin Microbiol"},{"key":"3009_CR36","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1128\/JCM.00201-10","volume":"48","author":"VS Kiet","year":"2010","unstructured":"Kiet VS, Lan NTN, An DD, Dung NH, Hoa DV, Chau NVV, et al. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2010;48:2934\u20139.","journal-title":"J Clin Microbiol"},{"key":"3009_CR37","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/jac\/dkm061","volume":"59","author":"JY Wang","year":"2007","unstructured":"Wang JY, Lee LN, Lai HC, Wang SK, Jan IS, Yu CJ, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J Antimicrob Chemother. 2007;59:860\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"3009_CR38","doi-asserted-by":"publisher","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","volume":"7","author":"S Malik","year":"2012","unstructured":"Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. PLoS One. 2012;7:e39754.","journal-title":"PLoS One"},{"key":"3009_CR39","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.5588\/ijtld.16.0199","volume":"20","author":"R Kumar","year":"2016","unstructured":"Kumar R, Garg R, Kant S, Verma SK, Kushwaha RA, Kumar S, Jain A. High correlation of clinical criteria in the diagnosis of drug-resistant TB and prevalence of ofloxacin resistance. Int J Tuberc Lung Dis. 2016;20:1354\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3009_CR40","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1128\/AAC.01036-07","volume":"52","author":"CA Peloquin","year":"2008","unstructured":"Peloquin CA, Hadad DJ, Molino LP, Palaci M, Boom WH, Dietze R, et al. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis. Antimicrob Agents Chemother. 2008;52:852\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR41","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1128\/JCM.00670-16","volume":"54","author":"R Singhal","year":"2016","unstructured":"Singhal R, Reynolds PR, Marola JL, Epperson LE, Arora J, Sarin R, et al. Sequence analysis of fluoroquinolone resistance-associated genes gyrA and gyrB in clinical Mycobacterium tuberculosis isolates from patients suspected of having multidrug-resistant tuberculosis in New Delhi, India. J Clin Microbiol. 2016;54:2298\u2013305.","journal-title":"J Clin Microbiol"},{"key":"3009_CR42","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1086\/379328","volume":"37","author":"AS Ginsburg","year":"2003","unstructured":"Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, et al. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis. 2003;37:1448\u201352.","journal-title":"Clin Infect Dis"},{"key":"3009_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tube.2014.02.003","volume":"94","author":"N Singla","year":"2014","unstructured":"Singla N, Gupta D, Birbian N, Singh J. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity. Tuberculosis Elsevier Ltd. 2014;94:293\u20138.","journal-title":"Tuberculosis Elsevier Ltd"},{"key":"3009_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1128\/AAC.49.2.571-577.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Thomas M, Shinnick TM. Mutation of tlyA confers Capreomycin resistance in mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005;49:571\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR45","doi-asserted-by":"crossref","unstructured":"Sowajassatakul A, Prammananan T, Chaiprasert A, Phunpruch S. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M\/XDR-TB strains isolated in Thailand. BMC Microbiol. 2014;14:165","DOI":"10.1186\/1471-2180-14-165"},{"key":"3009_CR46","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1128\/AAC.00851-09","volume":"53","author":"L Jugheli","year":"2009","unstructured":"Jugheli L, Bzekalava N, De Rijk P, Fissette K, Portaels F, Rigouts L. High level of cross-resistance between kanamycin, amikacin, and capreomycin among mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother. 2009;53:5064\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"3009_CR47","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/jac\/dkq047","volume":"65","author":"J Evans","year":"2010","unstructured":"Evans J, Segal H. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in mycobacterium tuberculosis. J Antimicrob Chemother. 2010;65:897\u2013900.","journal-title":"J Antimicrob Chemother"},{"key":"3009_CR48","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/JCM.06860-11","volume":"50","author":"X Yuan","year":"2012","unstructured":"Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, et al. Molecular characterization of multidrug- and extensively drug-resistant mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol. 2012;50:2404\u201313.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3009-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T19:48:18Z","timestamp":1603914498000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3009-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3009"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3009-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethical Committee of Pasteur Institute of Morocco, and written informed consent was obtained from each study subject.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"98"}}